Allergan Said to Be Exploring Breaking Up Into 2 Businesses

Updated on

Allergan Plc, the $121 billion pharmaceutical company created through a merger with Actavis Plc, is exploring a breakup of the company, people with knowledge of the matter said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.